Alba Sánchez-Velázquez

12PUBLICATIONS
24CO-AUTHORS
Medical mycologyAllergyHaematological tumoursRheumatology and arthritisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 23, 2023
Mogamulizumab combined with extracorporeal photopheresis for the treatment of refractory mycosis fungoides and Sézary syndrome. Report of seven cases.

C A Rubio-Muniz, A Sánchez-Velázquez, J Arroyo-Andrés

|Jun 15, 2022
Apremilast: A novel adjuvant treatment for refractory isotretinoin-induced acne fulminans.

Alba Sánchez-Velázquez, Daniel Falkenhain-López, Jorge Arroyo-Andrés

|Apr 15, 2022
Real-life experience of using pegylated liposomal doxorubicin in primary cutaneous T-cell lymphomas.

Daniel Falkenhain-López, Mario Puerta-Peña, Jon Fulgencio-Barbarin

|Feb 08, 2022
Two clinical subtypes with different management of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: A single centre experience.

Daniel Falkenhain-López, Alba Sánchez-Velázquez, Jon Fulgencio-Barbarin

|Jan 30, 2022
Two cases of generalized eruptive lentiginosis in cutaneous T-cell lymphoma following mogamulizumab treatment.

Cristina Vico-Alonso, Alba Sánchez-Velázquez, Mario Puerta-Peña

|Sep 16, 2021
Single-centre experience of using pegylated liposomal doxorubicin as maintenance treatment in mycosis fungoides.

D Falkenhain-López, J Fulgencio-Barbarin, M Puerta-Peña

Pageof 2

Frequent Collaborators

9 joint publications

Daniel Falkenhain-López

4 joint publications

Mario Puerta-Peña

4 joint publications

Jorge Arroyo-Andrés

3 joint publications

Jon Fulgencio-Barbarin